Author:
Agostinetto Elisa,Gombos Andrea,Piccart Martine
Publisher
Springer International Publishing
Reference261 articles.
1. Zhou J, Giannakakou P. Targeting microtubules for cancer chemotherapy. Curr Med Chem Anticancer Agents. 2005;5(1):65–71.
2. Martín M, Ruiz Simón A, Ruiz Borrego M, Ribelles N, Rodríguez-Lescure Á, Muñoz-Mateu M, et al. Epirubicin plus cyclophosphamide followed by docetaxel versus Epirubicin plus docetaxel followed by Capecitabine as adjuvant therapy for node-positive early breast cancer: results from the GEICAM/2003-10 study. J Clin Oncol Off J Am Soc Clin Oncol. 2015;33(32):3788–95.
3. Tannock I, Hill R, Bristow R, Harrington L. The basic science of oncology. 4th ed. New York: McGraw-Hil; 2005.
4. Kaye SB. New antimetabolites in cancer chemotherapy and their clinical impact. Br J Cancer. 1998;78(Suppl 3):1–7.
5. Takimoto C, Calvo E. Principles of oncologic pharmacotherapy. In: Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ, editors. Cancer management: a multidisciplinary approach, vol. 11. London: CMP; 2008.